title: Prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia.
abstract: BACKGROUND
  Metabolic symptoms induced by antipsychotic medication have been widely documented but there have been few studies comparing the effect of commonly used atypical antipsychotics on blood glucose and lipids among individuals with first-onset schizophrenia.
  
  
  METHODS
  A total of 150 patients with first-onset schizophrenia were randomized into three groups and each group was treated with olanzapine, quetiapine, or aripiprazole for eight weeks. Blood glucose and lipids (including levels of triglyceride, total cholesterol, low-density lipoprotein, and high-density lipoprotein) were tested at baseline and at the end of the 8 weeks of treatment.
  
  
  RESULTS
  Fasting blood glucose increased significantly over the 8 weeks in the olanzapine group but not in the quetiapine or aripiprazole groups. Based on a repeated measures analysis of variance, triglyceride levels increased significantly over the 8 weeks of treatment and high-density lipoprotein decreased significantly over the 8 weeks of treatment. The increase in triglyceride in the olanzapine and quetiapine groups was greater than that in the aripiprazole group, and the decrease in high-density lipoprotein was greater in the olanzapine and quetiapine groups than in the aripiprazole groups.
  
  
  CONCLUSIONS
  During the first 8 weeks of treatment of drug-naïve patients with schizophrenia, olanzapine has a greater effect on blood glucose than quetiapine or aripiprazole, and both olanzapine and quetiapine have a greater effect on blood lipids than aripiprazole.
authors: Kangle Hospital, Zhangjiagang City, Jiangsu Province, China.
authors: Shufen
authors: S
authors: Zhang
authors: First affiliated Hospital of Suzhou University, Suzhou, Jiangsu Province, China.
authors: Guanghua
authors: G
authors: Lan
keywords: China; antipsychotic medication; aripiprazole; carbohydrate metabolism; first-episode; lipid metabolism; olanzapine; quetiapine; schizophrenia
references: J Am Coll Cardiol. 2004 Mar 3;43(5):717-24
references: 14998606
references: N Engl J Med. 1965 Oct 28;273(18):947-52
references: 5831733
references: Am J Psychiatry. 2003 Aug;160(8):1396-404
references: 12900300
references: Am J Psychiatry. 1999 Nov;156(11):1686-96
references: 10553730
references: Curr Pharm Des. 2004;10(18):2219-29
references: 15281897
references: Psychiatr Clin North Am. 2007 Sep;30(3):401-16
references: 17720029